Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients

키워드

참고문헌 (40)

1. Patel R, "Significance of the positive crossmatch test in kidney transplantation", N Engl J Med, 280, pp.735~739 (1969)
2. Stiller CR, "Lymphocyte-dependent antibody and renal graft rejection", Lancet, 1, pp.953~954 (1975)
3. Orandi BJ, "Quantifying the risk of incompatible kidney transplantation : a multicenter study", Am J Transplant, 14, pp.1573~1580 (2014)
4. Tait BD, "Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation", Transplantation, 95, pp.19~47 (2013)
5. Johnson AH, "Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test : identification of low levels of pre-formed antibodies in accelerated allograft rejection", Tissue Antigens, 2, pp.215~226 (1972)
6. Couzi L, "Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay", Transplantation, 91, pp.527~535 (2011)
7. Batal I, "Antihuman leukocyte antigen-specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches", Arch Pathol Lab Med, 134, pp.1534~1540 (2010)
8. Lefaucheur C, "Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation", J Am Soc Nephrol, 21, pp.1398~1406 (2010)
9. Zecher D, "Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen", Nephrol Dial Transplant, 32, pp.730~737 (2017)
10. Mujtaba MA, "The strength of donor-specific antibody is a more reliable predictor of antibody-mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients", Clin Transplant, 25, pp.E96~102 (2011)
11. Montgomery RA, "Desensitization in HLA-incompatible kidney recipients and survival", N Engl J Med, 365, pp.318~326 (2011)
12. Sethi S, "Desensitization : overcoming the immunologic barriers to transplantation", J Immunol Res, 2017, pp.6804678~ (2017)
13. 박요한, "Kidney transplantation in highly sensitized recipients", Kidney Research and Clinical Practice, 40(3), pp.355~370 (2021), 대한신장학회[DOI]
14. Salvadé I, "Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation", Hum Immunol, 77, pp.483~489 (2016)
15. Mohan S, "Donor-specific antibodies adversely affect kidney allograft outcomes", J Am Soc Nephrol, 23, pp.2061~2071 (2012)
16. Buttigieg J, "Positive Luminex and negative flow cytometry in kidney transplantation : a systematic review and meta-analysis", Nephrol Dial Transplant, 34, pp.1950~1960 (2019)
17. Malheiro J, "Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation", Transpl Immunol, 32, pp.66~71 (2015)
18. Chung BH, "Clinical impact of the baseline donor-specific anti-human leukocyte antigen antibody measured by Luminex single antigen assay in living donor kidney transplant recipients after desensitization therapy", Transpl Int, 27, pp.49~59 (2014)
19. Kim Y, "Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants", Ann Clin Lab Sci, 40, pp.330~335 (2010)
20. 장지영, "Application of Calculated Panel Reactive Antibody Using HLA Frequencies in Koreans", Annals of Laboratory Medicine, 32(1), pp.66~72 (2012), 대한진단검사의학회
21. Hwang SD, "Effect of pretransplant rituximab use on posttransplant clinical outcomes in patients with high panel reactive antibody scores", Nephron, 130, pp.239~244 (2015)
22. Loupy A, "Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnostics", Kidney Int, 101, pp.678~691 (2022)
23. Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)
24. Razonable RR, "Cytomegalovirus in solid organ transplant recipients–Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice", Clin Transplant, 33, pp.e13512~ (2019)
25. Hirsch HH, "BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice", Clin Transplant, 33, pp.e13528~ (2019)
26. Higgins R, "Human leukocyte antigen antibody-incompatible renal transplantation : excellent medium-term outcomes with negative cytotoxic crossmatch", Transplantation, 92, pp.900~906 (2011)
27. Kamburova EG, "Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant", Am J Transplant, 18, pp.2274~2284 (2018)
28. Ziemann M, "Preformed donor-specific HLA antibodies in living and deceased donor transplantation : a multicenter study", Clin J Am Soc Nephrol, 14, pp.1056~1066 (2019)
29. Hart A, "OPTN", SRTR 2019 annual data report : kidney, 2021, pp.21(Suppl 2), 21~137
30. Laging M, "Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable", Transplantation, 97, pp.330~336 (2014)
31. Roodnat JI, "The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis", Transplantation, 75, pp.2014~2018 (2003)
32. Koo DD, "Cadaver versus living donor kidneys : impact of donor factors on antigen induction before transplantation", Kidney Int, 56, pp.1551~1559 (1999)
33. Zhang R, "Donor-specific antibodies in kidney transplant recipients", Clin J Am Soc Nephrol, 13, pp.182~192 (2018)
34. Hirai T, "Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection", Transpl Int, 25, pp.925~934 (2012)
35. Willicombe M, "et al Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy", Am J Transplant, 11, pp.470~477 (2011)
36. Aubert O, "Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients", J Am Soc Nephrol, 28, pp.1912~1923 (2017)
37. 박우영, "Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection", Clinical Transplantation and Research, 35(1), pp.33~40 (2021), 대한이식학회[DOI]
38. Montgomery RA, "HLA in transplantation", Nat Rev Nephrol, 14, pp.558~570 (2018)
39. Avery RK, "Quantifying infection risks in incompatible living donor kidney transplant recipients", Am J Transplant, 21, pp.1564~1575 (2021)
40. Chung BH, "Combined use of rituximab and plasmapheresis pre-transplant increases post-transplant infections in renal transplant recipients with basiliximab induction therapy", Transpl Infect Dis, 15, pp.559~568 (2013)

관련 논문AI추천